Recent progress in thiocarbazone metal complexes for cancer therapy via mitochondrial signalling pathway

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology and Toxicology
• Cancer Research

Background:

• Mitochondria are crucial for cellular energy, apoptosis, and metabolic regulation, making them key targets for cancer therapy.
• Thiosemicarbazone metal complexes are emerging as promising anticancer agents by targeting mitochondrial function.
• Disrupting mitochondrial membrane potential initiates apoptosis, leading to cancer cell death.

Purpose of the Study:

• To review the structural diversity of thiosemicarbazone metal complexes.
• To explore the anticancer mechanisms of these complexes that target mitochondrial pathways.
• To highlight their potential as novel therapeutic agents for cancer treatment.

Main Methods:

• Literature review of thiosemicarbazone metal complexes.
• Analysis of structural variations in metal complexes (Fe(III), Cu(II), Ni(II), Zn(II), Ga(III), Pb(II), Au(III), Ir(III)).
• Examination of mechanisms targeting mitochondrial pathways, including membrane potential disruption and apoptosis induction.

Main Results:

• Thiosemicarbazone metal complexes exhibit significant structural diversity.
• These complexes effectively target mitochondria, leading to a reduction in mitochondrial membrane potential.
• The disruption of mitochondrial membrane potential triggers apoptosis in cancer cells.

Conclusions:

• Thiosemicarbazone metal complexes represent a promising class of anticancer agents.
• Their efficacy is linked to their ability to target and disrupt mitochondrial function, inducing apoptosis.
• Further research into these complexes could lead to innovative cancer treatment strategies.